Clinical Trial Update: Circulating microRNAs as Disease Markers in Pediatric Cancers

View source ↗

Summary

A completed study evaluating circulating microRNAs as biomarkers for pediatric cancers, including leukemia, lymphoma, and central nervous system neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Neoplasms
• Leukemia
• Lymphoma

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Leukemia, Lymphoma | Status: COMPLETED